Randomized, proof-of-principle clinical trial of active transcranial magnetic stimulation in chronic migraine
dc.contributor.author | Conforto, Adriana B. | |
dc.contributor.author | Amaro, Edson | |
dc.contributor.author | Goncalves, Andre L. | |
dc.contributor.author | Mercante, Juliane P. P. | |
dc.contributor.author | Guendler, Vera Z. | |
dc.contributor.author | Ferreira, Josione R. | |
dc.contributor.author | Kirschner, Clara C. F. B. | |
dc.contributor.author | Peres, Mario F. P. [UNIFESP] | |
dc.contributor.institution | Hosp Israelita Albert Einstein | |
dc.contributor.institution | Universidade de São Paulo (USP) | |
dc.contributor.institution | Universidade Federal de São Paulo (UNIFESP) | |
dc.date.accessioned | 2016-01-24T14:37:16Z | |
dc.date.available | 2016-01-24T14:37:16Z | |
dc.date.issued | 2014-05-01 | |
dc.description.abstract | Background High-frequency repetitive transcranial magnetic stimulation of the left dorsolateral prefrontal cortex (rTMS-DLPFC) is an effective treatment for depression. Preliminary studies indicated beneficial effects of rTMS-DLPFC on pain relief in patients treated for depression, and in patients with chronic migraine.Methods in this randomized, double-blind, parallel-group, single-center, proof-of-principle clinical trial, we tested the hypothesis that 23 sessions of active rTMS-DLPFC delivered over eight weeks would be feasible, safe and superior to sham rTMS to decrease the number of headache days in 18 patients with chronic migraine without severe depression. Per-protocol analysis was performed.Results rTMS-DLPFC applied over eight weeks was feasible and safe in patients with chronic migraine. Contrary to our primary hypothesis, the number of headache days decreased significantly more in the sham group than in the group treated with active rTMS-DLPFC at eight weeks. Average decrease in headache days was >50% in the sham group, indicating a powerful placebo response. Pain intensity improved in both groups to a similar extent.Conclusions Positive results of M1 stimulation in other studies, and the absence of significant benefits of active high-frequency rTMS of the DLPFC in the present study, point to M1 as a more promising target than the DLPFC, for larger trials of noninvasive brain stimulation in patients with chronic migraine. | en |
dc.description.affiliation | Hosp Israelita Albert Einstein, Inst Israelita Ensino & Pesquisa, BR-05601901 São Paulo, Brazil | |
dc.description.affiliation | Univ São Paulo, Hosp Clin São Paulo Univ, Clin Neurol Div, BR-05508 São Paulo, Brazil | |
dc.description.affiliation | Univ São Paulo, Ctr Interdisciplinary Res Appl Neurosci NAPNA, BR-05508 São Paulo, Brazil | |
dc.description.affiliation | Hosp Clin São Paulo Univ, Inst Radiol, São Paulo, Brazil | |
dc.description.affiliation | Universidade Federal de São Paulo, Neurol & Neurosci Postgrad Program, São Paulo, Brazil | |
dc.description.affiliationUnifesp | Universidade Federal de São Paulo, Neurol & Neurosci Postgrad Program, São Paulo, Brazil | |
dc.description.source | Web of Science | |
dc.description.sponsorship | Albert Einstein Israelite Hospital Teaching and Research Institute/Instituto de Ensino e Pesquisa do Hospital Israelita Albert Einstein | |
dc.description.sponsorship | Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) | |
dc.description.sponsorshipID | Albert Einstein Israelite Hospital Teaching and Research Institute/Instituto de Ensino e Pesquisa do Hospital Israelita Albert Einstein: IEP.PE.08-0122 | |
dc.description.sponsorshipID | CNPq: 472407/2007-4 | |
dc.format.extent | 464-472 | |
dc.identifier | http://dx.doi.org/10.1177/0333102413515340 | |
dc.identifier.citation | Cephalalgia. London: Sage Publications Ltd, v. 34, n. 6, p. 464-472, 2014. | |
dc.identifier.doi | 10.1177/0333102413515340 | |
dc.identifier.issn | 0333-1024 | |
dc.identifier.uri | http://repositorio.unifesp.br/handle/11600/37754 | |
dc.identifier.wos | WOS:000334157600009 | |
dc.language.iso | eng | |
dc.publisher | Sage Publications Ltd | |
dc.relation.ispartof | Cephalalgia | |
dc.rights | info:eu-repo/semantics/restrictedAccess | |
dc.rights.license | http://www.uk.sagepub.com/aboutus/openaccess.htm | |
dc.subject | Placebo | en |
dc.subject | dorsolateral prefrontal cortex | en |
dc.subject | transcranial magnetic stimulation | en |
dc.subject | chronic migraine | en |
dc.subject | pain | en |
dc.title | Randomized, proof-of-principle clinical trial of active transcranial magnetic stimulation in chronic migraine | en |
dc.type | info:eu-repo/semantics/article |